PRESS RELEASE published on 02/28/2025 at 07:30, 1 year 7 months ago LR Health & Beauty SE achieves significant sales growth in the final quarter of 2024 and meets the sales and earnings forecast for the full year 2024 LR Health & Beauty SE reports significant sales growth of 8.0% in Q4 2024, reaching EUR 76.5 million. Full-year sales at EUR 289.2 million, meeting forecasts. Positive momentum from new products and realigned career plan Earnings Forecast Sales Growth LR Health & Beauty SE Product Launches Q4 2024
BRIEF published on 02/26/2025 at 15:35, 1 year 7 months ago LR Health & Beauty SE Seeks Nasdaq Stockholm Bond Listing Bond Prospectus Nasdaq Stockholm Financial Strategy Investor Information Corporate Bonds
BRIEF published on 02/26/2025 at 15:35, 1 year 7 months ago LR Health & Beauty SE cherche à s'introduire en bourse sur le Nasdaq Stockholm Stratégie Financière Nasdaq Stockholm Informations Pour Les Investisseurs Obligations D'entreprises Prospectus D'obligations
PRESS RELEASE published on 02/26/2025 at 15:30, 1 year 7 months ago LR Health & Beauty SE publishes bond prospectus and applies for admission to trading of bonds on the corporate bond list of Nasdaq Stockholm LR Health & Beauty SE publishes bond prospectus and applies for trading of bonds on Nasdaq Stockholm's corporate bond list; LR Group's holistic business model and commitment to sustainability showcased Sustainability Bond Prospectus Nasdaq Stockholm LR Health & Beauty LR Group
BRIEF published on 11/26/2024 at 12:52, 1 year 10 months ago LR Health & Beauty SE Sees Growth in Q3 2024 EBITDA Forecast LR Health & Beauty Third Quarter Growth 2024 Sales Increase Distributor Strategy
BRIEF published on 11/26/2024 at 12:52, 1 year 10 months ago LR Health & Beauty SE enregistre une croissance au troisième trimestre 2024 LR Santé & Beauté Croissance Au Troisième Trimestre Prévision De L'EBITDA Augmentation Des Ventes En 2024 Stratégie De Distribution
BRIEF published on 11/26/2024 at 12:50, 1 year 10 months ago LR Health & Beauty SE Adjusts 2024 Financial Forecasts Amid Sales Growth Financial Performance 2024 Forecast Adjustment Q3 Sales Growth EBITDA Changes Distributor Realignment
BRIEF published on 11/26/2024 at 12:50, 1 year 10 months ago LR Health & Beauty SE ajuste ses prévisions financières pour 2024 en raison de la croissance des ventes Performance Financière Croissance Des Ventes Au 3e Trimestre Ajustement Des Prévisions Pour 2024 Évolution De L'EBITDA Réalignement Des Distributeurs
PRESS RELEASE published on 11/26/2024 at 12:47, 1 year 10 months ago LR Health & Beauty SE further increases growth trend in the third quarter LR Health & Beauty SE reports 7.2% sales growth in Q3 2024, with EBITDA rising. LR ZEITGARD Signature boosts sales. Adjusted guidance for 2024: Sales range EUR 288M to EUR 292M, EBITDA EUR 26M to EUR 29M EBITDA Sales Growth Financial Forecast LR Health & Beauty SE LR ZEITGARD Signature
PRESS RELEASE published on 11/26/2024 at 12:45, 1 year 10 months ago EQS-Adhoc: LR Health & Beauty SE: Publication of figures for the third quarter of 2024 and adjustment of the forecast for the 2024 financial year LR Health & Beauty SE reports increase in sales for Q3 2024, adjusts forecast for full year. Sales guidance raised to EUR 288-292 million, EBITDA forecast revised to EUR 26-29 million Forecast Adjustment EBITDA Forecast Sales Increase LR Health & Beauty SE 2024 Financial Year
Published on 10/03/2026 at 02:35, 1 day 16 hours ago Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 13:50, 2 days 5 hours ago AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 2 days 6 hours ago Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 2 days 6 hours ago Alaska Energy Metals Appoints Independent Director, Thomas Benson
Published on 10/04/2026 at 06:05, 13 hours 12 minutes ago Blokees Debuts 90+ New Products at Wonder Festival Shanghai 2026
Published on 10/04/2026 at 05:15, 14 hours 2 minutes ago SIBIONICS and PharmaSens Explore New Horizons for Automated Insulin Delivery at EASD 2026
Published on 10/03/2026 at 15:45, 1 day 3 hours ago Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 1 day 19 hours ago IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day 22 hours ago EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 17:45, 2 days 1 hour ago Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 2 days 1 hour ago Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 2 days 1 hour ago Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 2 days 1 hour ago Aéroports de Paris SA - Calendrier financier 2027